A lawsuit filed by a physician’s group against Stryker (NYSE:SYK) won its 3rd bid for class action status this week, after a federal judge in Michigan agreed to set the terms for eligibility for the class.
Stryker
Hologic hands corner office to former Stryker chief, takes on 2 Icahn board members
Cook Medical continues to shuffle management | Personnel Moves
Cook Medical named Rob Lyles executive vice president, the latest move in a larger management shift at the Indiana medtech maker.
Lyles was formerly vice president of Cook’s peripheral intervention division. He has been with the company since 2003 and was named division VP in 2007. Lyles’ promotion follows the advancement of Pete Yonkman to president of the Cook Medical. Mark Breedlove, a 19-year veteran of Cook Medical, will succeed Lyles as VP of the peripheral intervention division.
Mako Surgical settles shareholders’ lawsuits ahead of Stryker buyout
Veran medical adds former Stryker CFO Hartman to board | Personnel Moves
MassDevice.com Q&A: Skyline Medical CEO Josh Kornberg
When John Kornberg joined then-BioDrain Medical in 2011 as an investor, the company had spent the past decade developing its Streamway surgical waste management device and getting clearance to commercialize it in the U.S. But, Kornberg told MassDevice.com recently, it was quickly apparent that BioDrain was stalled, unable to leverage its 510(k) clearance from the FDA into significant U.S. sales.
Brokers plead guilty to insider trading of Stryker stock
Mako’s Q3 numbers drop, outlook clears in the midst of Stryker merger
SEC levels FCPA charges against Stryker
Rumor: Stryker to pay $30M for ActiViews
Stryker nearly doubles estimate on recall costs
Stryker (NYSE:SYK) said yesterday that the cost of the recalls of its Rejuvenate and ABG II hip implants could top $1 billion, nearly double its prior estimate.
The Kalamazoo, Mich.-based orthopedic medical device company said in a regulatory filing that it now expects the recalls to cost between $700 million and $1.13 billion.